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1. Introduction
The growing trend of childhood obesity represents a major 
health concern worldwide (1). It is now well documented 
that obesity is linked to increased cardiovascular 
disease (CVD) risk in adults (2). However, even if CVD 
complications usually become manifested in adulthood, 
the process of atherogenesis might start much earlier. 
To date, a body of evidence has been gathered implying 
that atherosclerosis may begin in childhood (3). Taken all 
together, childhood obesity seems to be significant risk 
factor for the onset of CVD (4). 
Although there is no doubt that any strategy for 
prevention of atherosclerosis should include children and 
adolescents, there is no consensus regarding independent 
association of childhood obesity with CVD risk factors 
in later life (5). However, it has been demonstrated that 
overweight and obese children have a greater likelihood 
of developing hypertension and type-2 diabetes, as well as 
ischemic heart and brain diseases (6). In general, obesity 
is associated with numerous metabolic abnormalities 
(3), which may magnify cardiovascular risk. Excessive 
adipose tissue accumulation results in the release of 
several adipokines that contribute to the pathogenesis 
of inflammation and hypertension (7). Apart from 
inflammation, abnormalities in serum lipid levels are 
also typically seen in obesity. Although increased low-
density lipoprotein (LDL)-cholesterol (LDL-C) and low 
high-density lipoprotein (HDL)-cholesterol (HDL-C) 
concentrations are well-known as major atherosclerosis 
risk factors, it is now recognized that certain lipoprotein 
subclasses, particularly small, dense LDL and HDL, 
may further distinguish an individual’s CVD risk (8). In 
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accordance, atherogenic dyslipidemia has emerged as an 
increasingly prevalent risk factor in children, concomitant 
with obesity (9).
It is well known that predisposition to obesity is 
determined by genetic and environmental risk factors. 
On the other hand, the concept that fetal life is a critical 
time for lifelong cardiovascular consequences is also 
well supported (10). According to the available evidence, 
gestational obesity is able to predispose the offspring to the 
development of CVD in adulthood (11). We have recently 
demonstrated that higher proportions of small, dense 
LDL particles in maternal plasma before delivery were 
independently associated with smaller weight and length 
of newborns (12). A low size at birth, related to suboptimal 
fetal environment, has been associated with obesity risk in 
childhood (13) but also with increased rate of metabolic 
diseases in later life (14). In addition, Apgar score, an 
indicator of a newborn’s vitality, can also offer additional 
prognostic information on future morbidity and mortality 
(15). So far, there have been no studies on the association 
between neonatal data and lipoprotein subclasses profile 
in obese children.
Another important aspect related to further 
cardiovascular health of the child is dietary pattern 
during the early postnatal period. Nowadays, exclusive 
breastfeeding is considered the optimal source of nutrition 
in early life (16). Moreover, breastfeeding has been found 
to be protective against development of atherosclerosis in 
terms of reducing CVD risk factors (17). In the reviewed 
literature, there is no study investigating the impact of 
breastfeeding on lipoprotein subclasses distribution in 
obese children. 
 In this study we aimed to evaluate possible 
associations of neonatal data (Apgar score, birth weight, 
and birth length) with LDL and HDL subclasses in 
a group of obese children. In addition, we examined 
whether breastfeeding duration had an impact on obesity-
associated lipoprotein subclass distributions.
2. Materials and methods 
2.1. Patients
The study included obese children who attended medical 
check-ups at the University Children’s Hospital. The 
inclusion criteria were absence of secondary hypertension 
and obesity associated with any medical conditions, as 
well as use of any medication. As a result, a total group 
of 42 subjects, aged 10–18 years, who had completed all 
required data and measurements were included in the 
study. Neonatal data were gathered from medical records 
and included Apgar score, birth weight, and birth height. 
Breastfeeding was considered as any kind of breastfeeding, 
i.e. exclusive and partial breastfeeding. Duration of 
breastfeeding was self-reported by parents. 
The study was executed following the ethical guidelines 
of the Declaration of Helsinki. The study protocol was 
approved by the institutional review committee. All 
patients and their parents were completely informed and 
gave written consent for participation.
2.2. Anthropometric measurements
Each patient’s weight, height, waist, and hip circumferences 
were measured. Body-mass index (BMI) and BMI z-score 
values were calculated according to a previously proposed 
model (18). Childhood obesity was considered if BMI was 
≥95th percentile.
2.3. Laboratory analyses
Blood samples were collected into evacuated tubes 
containing EDTA and serum sample tubes after a 12-h 
fasting period. Plasma and serum were separated by 
immediate centrifugation at 1500 × g for 10 min at 4 °C. 
Aliquots of each sample were stored at −80 °C and thawed 
immediately before analyses.
Concentrations of glucose, total cholesterol (TC), 
triglycerides (TG), LDL-C, and HDL-C were measured 
by routine laboratory methods (Olympus Diagnostica 
GmbH, Hamburg, Germany). LDL and HDL subclasses 
were measured by the modified method of Rainwater et al. 
(19), as previously published in detail (20). We determined 
migration distances for absorbance peaks and used them 
for assessment of the particle diameter. Diameters of the 
most prominent peaks in the LDL and HDL regions of each 
scan were labelled as dominant particle sizes. The areas 
under the peaks corresponding to each LDL and HDL 
subclass were also determined and referred to as relative 
proportions of particular subfractions. The proportion 
of small, dense LDL was also ascertained as the area at 
or below 25.5 nm in the densitometric scan. Likewise, 
percentage of small, dense HDL particles was determined 
as the area of the densitometric scan at or below 8.8 nm 
(20). Increased small, dense LDL particle proportion was 
considered if the absorbance in the region corresponding 
to LDL size ≤ 25.5 nm was higher than 50% (19). All assays 
were performed blindly.
2.4. Statistical analysis
Normally distributed continuous variables were shown 
as mean ± standard deviation (SD). Variables that did 
not fit into normal distribution were presented as median 
(interquartile range), and categorical variables as relative 
or absolute frequencies. Group differences were analyzed 
by Student’s t-test (if the data were normally distributed) 
or by Mann–Whitney test (if the data were asymmetrical). 
Categorical data were analyzed by chi-square test. We 
employed Spearman’s correlation analysis for assessment 
of significant associations. Minimal statistical significance 
was set at P < 0.05 and the statistical software MedCalc for 
Windows version 9.6.3. (Mariakerke, Belgium) was used 
for analysis.
1806
BEKHET et al. / Turk J Med Sci
3. Results
Table 1 represents the demographic and laboratory data 
of 42 obese children. The study participants were 14.2 ± 
2.1 years old and 37 of them (88.1%) were pubertal. All 
children had BMI above the 95th percentile and were 
characterized by central obesity, as indicated by high waist-
to-hip ratios (range: 0.82–1.04). Regarding neonatal data, 
all children were born at term. Normal birth weight had 
35 (83.3%) participants, 6 (14.3%) had high birth weight 
(>4000 g), and one child had low birth weight (<2500 g). 
According to Apgar rating, 10 infants (23.8%) had a score 
less than 9, including three subjects with a score less than 
7. Data on breastfeeding were available for 40 children. 
Among them, 85% were breastfed for at least 1 month 
(median: 7.5 months). 
The study participants were initially classified 
according to the Apgar score (Table 2). The two groups 
were homogeneous in terms of age and sex. Obese 
children with Apgar < 9 had significantly lower birth 
weight than the group with Apgar ≥ 9. On the other hand, 
anthropometric variables (weight, BMI, waist and hip 
circumferences) in childhood did not differ between the 
groups. Similarly, no differences in lipid status parameters 
were detected. Compared with the children with Apgar ≥ 
9, the group with Apgar < 9 showed a tendency toward 
smaller LDL and HDL particles sizes (P = 0.098 and P = 
0.087, respectively). Furthermore, the children with Apgar 
< 9 had significantly increased proportion of LDL III (P < 
0.05) with parallel reduction in LDL I subclasses (P < 0.01) 
than those with Apgar ≥ 9. As a result, the proportion 
of small, dense LDL particles was significantly higher in 
the children with Apgar < 9 (P < 0.05). HDL subclasses 
distribution did not differ between the groups.  
Next, we performed Spearman’s correlation analysis 
(Table 3) and found that Apgar score was in positive 
correlation with LDL size and relative proportions of LDL 
I subclasses, and in inverse correlation with the percentage 
of small, dense LDL particles. Moreover, Apgar score was 
positively associated with the proportions of HDL 3a 
subclasses. 
With regard to the previous findings, we additionally 
analyzed potential associations of lipoprotein heterogeneity 
with birth size (Table 3). We found that birth weight was 
positively related to the proportions of LDL I and inversely 
associated with the proportions of HDL 3c subclasses 
(Table 3). No significant correlations were found between 
birth height and LDL subclasses. On the other hand, HDL 
size and relative proportions of HDL 2b particles were 
positively associated, while the proportions of HDL 3c 
were in negative correlation with birth height. 
In further analysis, we examined the impact of 
breastfeeding on clinical and laboratory parameters in 
childhood (Table 4). Eight children did not breastfeed at 
Table 1. Clinical and laboratory parameters of study participants. 
Obese children
(n = 42)
Age, years 14.2 ± 2.1
Sex, boys/girls 30/12
Prepubertal/pubertal 5/37
Apgar score 8.7 ± 1.3
Birth weight, g 3392.6 ± 587.4
Birth length, cm 52.4 ± 3.5
Breastfeeding, % 85
Breastfeeding duration, months # 7.5 ± 3.13
Weight, kg 88 ± 20.0
Height, m 170 ± 12.8
BMI, kg/m2 30.2 ± 3.9
BMI percentile 97.2 ± 1.2
BMI z-score 3.14 ± 0.99
Waist circumference, cm 97 ± 9.4
Hip circumference, cm 103 ± 11.9
Waist-to-hip ratio 0.94 ± 0.06
Glucose, mmol/L 4.79 ± 0.57
TC, mmol/L 4.25 ± 1.14
LDL-C, mmol/L 2.74 ± 1.16
HDL-C, mmol/L 1.06 ± 0.24
TG, mmol/L # 0.88 (0.69–1.22)
LDL size, nm 27 ± 1.29
LDL I, % 21 ± 6.7
LDL II, % 24 ± 4.0
LDL III, % 20 ± 4.6
LDL IV, % 35 ± 8.4
Small, dense LDL, % 55 ± 9.4
HDL size, nm 9 ± 1.17
HDL 2b, % 40 ± 7.9
HDL 2a, % 19 ± 4.9
HDL 3a, % 15 ± 2.8
HDL 3b, % 9 ± 3.3
HDL 3c, % 17 ± 7.5
Small, dense HDL, % 41 ± 9.9
Data are presented as mean ± SD, and absolute or relative 
frequencies for categorical variables
#  Data are presented as median (IQR).
BMI, body-mass index; TC, total cholesterol; LDL, low-density 
lipoprotein; LDL-C, low-density lipoprotein cholesterol ; HDL, 
high-density lipoprotein; HDL-C, high-density lipoprotein 
cholesterol; TG, triglycerides.
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all, while seven children were breastfed for 1 or 2 months 
solely. On the other hand, 19 children were breastfed 
≥ 6 months (min. 6 months; max. 24 months) and six 
children were breastfed 3, 4, or 5 months. Due to unequal 
distribution of children, the study participants were 
classified according to breastfeeding duration into the 
group of never or less than 3 months breastfed children 
and the group of children who were breastfed for 3 months 
or more. The newly formed groups were even in term of 
age and sex. Analysis of neonatal data showed that children 
Table 2. Clinical and laboratory parameters according to Apgar score.  
Apgar < 9
(n = 10)
Apgar ≥ 9
(n = 9) P
Age, years 14.7 ± 2.1 14.1 ± 2.2 0.369
Sex, boys/girls 9/1 20/11 0.231
Apgar score 7.0 ± 1.5 9.3 ± 0.5 <0.001
Birth weight, g 2944 ± 667.4 3523 ± 496.5 <0.05
Birth length, cm 50 ± 4.5 53 ± 2.8 0.085
Weight, kg 96 ± 25.5 85 ± 17.8 0.149
Height, m 175 ± 12.8 168 ± 12.4 0.136
BMI, kg/m2 30.7 ± 5.4   30.0 ± 3.4 0.652
BMI z-score 3.22 ± 1.52 3.12 ± 0.81 0.807
Waist circumference, cm 98 ± 12.3 97 ± 8.5 0.870
Hip circumference, cm 106 ± 17.6 103 ± 9.7 0.383
Waist-to-hip ratio 0.93 ± 0.07 0.95 ± 0.05 0.286
Glucose, mmol/L 4.65 ± 0.49 4.85 ± 0.59 0.349
TC, mmol/L 4.09 ± 0.69 4.33 ± 1.26 0.582
LDL-C, mmol/L 2.53 ± 0.52 2.84 ± 1.31 0.476
HDL-C, mmol/L 1.04 ± 0.22 1.07 ± 0.25 0.731
TG, mmol/L # 1.02 (0.64–1.20) 0.86 (0.70–1.23) 0.870
LDL size, nm 26 ± 1.4 27 ± 1.2 0.098
LDL I, % 17 ± 3.1 22 ± 7.3 <0.01
LDL II, % 23 ± 3.8 25 ± 4.1 0.207
LDL III, % 22 ± 2.1 19 ± 4.9 <0.05
LDL IV, % 38 ± 7.2 34 ± 8.7 0.190
Small, dense LDL, % 60 ± 6.3 53 ± 9.9 <0.05
HDL size, nm 9 ± 0.8 10 ± 1.2 0.087
HDL 2b, % 41 ± 7.4 40 ± 8.1      0.770
HDL 2a, % 20 ± 6.6 18 ± 4.1 0.248
HDL 3a, % 14 ± 2.3 15 ± 2.9 0.146
HDL 3b, % 8 ± 3.3 10 ± 3.2 0.207
HDL 3c, % 17 ± 9.2 17 ± 6.8 0.970
Small, dense HDL, % 39 ± 10.2 42 ± 9.7 0.421
Data are presented as mean ± standard deviation, and absolute or relative frequencies for categorical 
variables. Continuous variables were analyzed by Student’s t-test. Categorical variables were analyzed 
by chi-square test.
# - Data are presented as median (IQR) and analyzed by Mann–Whitney U test.
BMI, body-mass index; TC, total cholesterol; LDL, low-density lipoprotein; LDL-C, low-density 
lipoprotein cholesterol ; HDL, high-density lipoprotein; HDL-C, high-density lipoprotein cholesterol; 
TG, triglycerides.
1808
BEKHET et al. / Turk J Med Sci
in the group breastfed ≥ 3 months had significantly higher 
Apgar score than those who were not breastfed at all or 
were breastfed for less than 3 months. Anthropometric 
variables did not differ between the two groups. Even if we 
did not find differences in lipid status parameters, further 
insight into the characteristics of lipoprotein particles 
showed that the group of never or less than 3 months 
breastfed children had significantly smaller LDL size (P 
< 0.01) and reduced proportion of HDL 2a particles (P < 
0.05) than their ≥3 months breastfed peers.
4. Discussion
Over the past decades the prevalence of obesity among 
children and adolescent has considerably increased 
(1). Hence, in view of the growing trends of childhood 
obesity, primary prevention in youths seems to be the 
main approach to combat the development of numerous 
metabolic consequences, particularly CVD (6). Although 
the concept of obesity-related dyslipidemia is well 
understood in adults, quantitative evaluation in pediatric 
population is more complex. Namely, even if serum lipid 
parameters in obese children and adults have similar 
levels, in terms of higher TG and reduced HDL-C, 
younger populations usually have desirable or slightly 
elevated LDL-C concentrations (21). In line with previous 
research, obese children in the current study showed no 
dramatic abnormalities in serum lipid parameters (Table 
1). However, our more in-depth analysis of lipid status 
revealed high proportions of small, dense LDL and HDL 
particles (Table 1), in spite of relatively optimal serum 
lipid parameters. Recently, LDL and HDL subclasses 
characteristics in a group of healthy children of the same 
origin were published by Zeljkovic et al. (22). Both small, 
dense LDL and HDL particles in the current study of obese 
children were higher when compared to the data from 
healthy children in the study by Zeljkovic et al. (22). A 
prevalence of small, dense LDL particles in obese children 
has been previously reported, although the results were not 
entirely consistent (9). In contrast, a relationship of small 
HDL particles with childhood obesity has been firmly 
established (23). To date, numerous studies provided solid 
evidence that small, dense LDL particles have the greatest 
atherogenic potential, due to easier penetration into 
arterial intima, longer retention in subendothelium, and 
higher oxidative susceptibility (8). It is well known that 
high HDL-cholesterol levels are associated with decreased 
cardiovascular risk. By reverse cholesterol transport 
HDL particles accept cholesterol from the periphery, 
such as arterial wall cells, and deliver it to the liver. 
Reverse cholesterol transport is the major mechanism 
of antiatherogenic effects of HDL (24). In addition, a 
hypothesis that smaller HDL particles have diminished 
anti-atherogenic capacity in the conditions associated 
with dyslipidemia, inflammation, and enhanced oxidative 
stress was also confirmed (24). Therefore, a finding of pro-
atherogenic small, dense LDL and HDL particles in obese 
children could indicate higher cardiovascular risk than 
anticipated by standard lipid measurement. 
So far, numerous risk factors in children have been 
evaluated in terms of possible association with increased 
CVD risk in later life. Recently reviewed data suggest that 
cardiovascular risk in adulthood is more likely associated 
Table 3. Correlations of lipoprotein subclasses with Apgar score, birth weight, and birth height. 
Lipoprotein subclasses Apgar score Birth weight, g Birth height, cm
LDL size, nm 0.365 * 0.161 0.146
LDL I, % 0.386 * 0.517 ** 0.164
LDL II, % 0.172 0.173 –0.013
LDL III, % –0.238 –0.186 –0.115
LDL IV, % –0.271 –0.020 –0.020
Small, dense LDL, % –0.306 * –0.047 –0.047
HDL size, nm 0.248 0.224 0.350 *
HDL 2b, % 0.002 0.165 0.357 *
HDL 2a, % –0.036 0.057 –0.033
HDL 3a, % 0.363 * 0.260 –0.002
HDL 3b, % 0.175 0.115 –0.157
HDL 3c, % –0.182 –0.348 * –0.322 *
Small, dense HDL, % –0.009 –0.139 –0.267
** P < 0.001; * P < 0.05
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with tracking of overweight and dietary habits while 
growing up, rather than with obesity in childhood (5). 
On the other hand, prospective data indicate an inverse 
association of smaller neonatal body size with the onset 
of CVD in adulthood (25). In recent years, great attention 
has been paid to analyzing the link between different 
biomarkers in maternal plasma and smaller birth size, 
as well as their consequences on further morbidity 
Table 4. Clinical and laboratory parameters according to breastfeeding duration. 
Breastfeeding
<3 months and
none (n = 15)
≥3 months
(n = 25)  P
Age, years 14.0 ± 2.1 14.4 ± 2.2 0.573
Sex, boys/girls 10/5 19/6 0.716
Apgar score 8.2 ± 1.7 9.0 ± 0.9 <0.05
Birth weight, g 3256 ± 638.5 3456 ± 571.9 0.312
Birth length, cm 52 ± 4.5 52 ± 2.7 0.653
Breastfeeding duration, months # 0 (0–1) 12 (5–13.5) <0.001
Weight, kg 87.1 ± 20.6 88.8 ± 20.6 0.801
Height, m 167 ± 12.6 171 ± 13.1 0.322
BMI, kg/m2 30.7 ± 4.1  29.9 ± 3.9 0.545
BMI z-score 3.32 ± 0.95 3.06 ± 1.06 0.427
Waist circumference, cm 97 ± 10.7 97 ± 8.9 0.987
Hip circumference, cm 103 ± 12.7 104 ± 11.9 0.764
Waist-to-hip ratio 0.95 ± 0.06 0.94 ± 0.06 0.608
Glucose, mmol/L 4.65 ± 0.52 4.84 ± 0.56 0.294
TC, mmol/L 4.15 ± 1.64 4.38 ± 0.76 0.546
LDL-C, mmol/L 2.82 ± 1.67 2.76 ± 0.78 0.612
HDL-C, mmol/L 1.09 ± 0.24 1.04 ± 0.25 0.868
TG, mmol/L # 0.83 (0.60–1.10) 1.02 (0.78–1.27) 0.125
LDL size, nm 26 ± 1.19 27 ± 1.32 <0.01
LDL I, % 19 ± 4.4 22 ± 7.9 0.176
LDL II, % 25 ± 3.1 24 ± 4.6 0.404
LDL III, % 20 ± 4.6 20 ± 4.6 0.887
LDL IV, % 36 ± 6.2 34 ± 9.8 0.529
Small, dense LDL, % 56 ± 6.9 54 ± 11.0 0.621
HDL size, nm 9 ± 1.36 9 ± 1.09 0.845
HDL 2b, % 41 ± 7.6 40± 8.3      0.684
HDL 2a, % 17 ± 5.0 20 ± 4.1 <0.05
HDL 3a, % 14 ± 3.1 15 ± 2.7 0.304
HDL 3b, % 10 ± 3.8 9 ± 2.9 0.443
HDL 3c, % 18 ± 8.2 16 ± 6.8 0.341
Small, dense HDL, % 42 ± 10.9 40 ± 9.3 0.502
Data are presented as mean ± standard deviation, and absolute or relative frequencies for categorical variables. 
Continuous variables were analyzed by Student’s t-test. Categorical variables were analyzed by chi-square test.
# - Data are presented as median (IQR) and analyzed by Mann–Whitney U test.
BMI, body-mass index; TC, total cholesterol; LDL, low-density lipoprotein; LDL-C, low-density lipoprotein 
cholesterol ; HDL, high-density lipoprotein; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides.
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and mortality risk of infants. In our previous study, we 
demonstrated independent associations between smaller 
LDL and HDL particles in maternal plasma before 
delivery and lower newborn’s size (12), indicating that 
adverse lipoprotein subclasses profile in pregnancy affects 
fetal growth. The current study extends our previous 
observation, showing that size at birth might be associated 
with lipoprotein subclasses distribution in childhood. Our 
finding of inverse associations of birth weight and length 
with relative proportions of the largest LDL and HDL 
particles (Table 3) suggests that regular fetal growth may 
have a positive influence on lipid profile in childhood, 
even in the presence of juvenile obesity. According to the 
“fetal programming” concept, a growth restriction in utero 
has an important impact on CVD risk in adulthood. The 
hypothesis has been supported by an inverse association 
between birth weight and subsequent blood cholesterol 
concentration (26), although some authors dispute this 
theory (27). In our obese children, both smaller birth length 
and height were related to increased proportion of small, 
dense HDL particles (Table 3). It has been established that 
obesity is associated not only with increased prevalence of 
small, dense HDL particles, but also with changes in their 
composition, which further affects their functionality (28). 
Bearing in mind that these particles have compromised 
atheroprotective potential (24), the observed inverse 
association of smaller birth size and increased smaller 
HDL could be another piece of the puzzle linking restricted 
fetal growth with future cardiovascular complications. It 
should also be stressed that, following systematic analysis 
of available data, Huxley et al. (27) concluded that the 
effect of impaired fetal growth on cholesterol level, 
and consequently on CVD risk, should be considered 
marginal. This is not surprising giving the fact that plasma 
cholesterol concentration per se has low predictive value 
for CVD. Moreover, this conclusion further supports the 
concept of advanced lipoprotein testing for cardiovascular 
prevention (29), starting from infancy onward.
Besides newborn size, optimal fetal environment is 
reflected by Apgar score. A lower Apgar score at birth is 
an indicator of poorer vitality of the newborn and it has 
been connected to later developmental disorders and risk 
of cancer (15). Yet, a link between Apgar score and CVD 
risk factors in childhood has not been investigated so far. 
According to our results, childhood obesity is unrelated to 
Apgar score, since the majority of the study participants 
had desirable Apgar values (Table 2). However, in our obese 
children lower Apgar score was also associated with lower 
birth weight (Table 2), suggesting that this specific scenario 
might further affect CVD risk. Indeed, this group of obese 
children was characterized by significant redistribution 
of LDL subclasses towards small, dense particles (Table 
2). A possible explanation of our results could lie in the 
fact that our obese children with lower Apgar score have 
comparable present values of anthropometric variables as 
their higher Apgar score counterparts (Table 2), suggesting 
that these children experienced accelerated growth. It has 
been demonstrated that rapid growth during infancy is 
associated with longer-term problems of obesity (30). 
Hence, subsequent accelerated weight gain could also be 
responsible for the observed accumulation of small, dense 
LDL particles in the group with Apgar < 9. Additionally, 
our for-the-first time documented inverse association 
between Apgar score and small, dense LDL particles 
(Table 3) forms the basis for exploring this link in future 
investigations. 
Nutrition in infancy seems to have important effect on 
both weight gain and lipoprotein metabolism. There is a 
consensus that breast milk and prolonged breastfeeding 
prevent long-term overweight and obesity (31). To the 
best of our knowledge, this study is the first to describe an 
impact of breastfeeding duration on lipoprotein subclasses 
distribution in obese children. Our analysis showed that 
never or less than 3 months breastfed children have smaller 
LDL size and less HDL 2 particles than children who were 
breastfed for 3 months or more (Table 4). The results of 
the studies investigating the impact of breastfeeding 
on serum lipid profile are inconclusive. Some authors 
reported that breastfeeding duration was inversely 
associated with LDL-C levels (32), while others found 
no significant association (33). On the other hand, use of 
nutrient enriched formula, as an alternative or supplement 
to breastfeeding, was associated with alteration in serum 
lipid profile of infants (34). In addition, Ravelli et al. 
(35) reported that adults who were exclusively breastfed 
had lower LDL-C and apolipoprotein B, as well as lower 
LDL/HDL ratio than their formula-fed peers. Our present 
findings extend previous observations (35) and provide 
additional evidence that consumption of breast milk is an 
important strategy to prevent CVD development from a 
young age. 
In conclusion, the results of the current study have 
shown significant associations of neonatal characteristics 
with LDL and HDL particle distributions in obese children. 
In particular, we have demonstrated that lower Apgar 
score (<9) and smaller newborn’s size are associated with 
pro-atherogenic LDL and HDL particles in childhood. 
In addition, our results point toward positive aspects of 
longer breastfeeding duration on lipoprotein particle 
distributions in obese children. 
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